![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospace.com/article/releases/intravacc-and-primrose-bio-announce-partnership-to-enhance-conjugate-vaccine-development/
https://www.globenewswire.com/news-release/2024/03/28/2853733/0/en/Intravacc-and-Primrose-Bio-Announce-Partnership-to-Enhance-Conjugate-Vaccine-Development.html
https://www.intravacc.nl/company/news-events/news-article-view?tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=64&cHash=6d429252b39f046658cd623ab4d2c1fb
https://www.globenewswire.com/news-release/2024/03/26/2852111/0/en/Intravacc-announces-positive-data-of-first-in-human-intranasal-OMV-based-vaccine-for-SARS-CoV-2.html
https://www.globenewswire.com//news-release/2024/01/16/2809631/0/en/Intravacc-Awarded-US-633K-CARB-X-Funding-to-Develop-a-Vaccine-that-Prevents-Gonorrhea-Infections.html
https://www.intravacc.nl/company/news-events/news-article-view?tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=60&cHash=2ea3e7d7c72798c240e9295961892c20
https://www.globenewswire.com//news-release/2023/12/20/2799111/0/en/Intravacc-launches-new-website-with-a-wealth-of-scientific-knowledge-to-elevate-vaccine-innovation.html
https://www.globenewswire.com//news-release/2023/09/19/2745296/0/en/Intravacc-announces-publication-of-In-Vitro-alternative-to-replace-animal-pyrogen-test-for-vaccines.html
https://www.globenewswire.com//news-release/2023/09/14/2742972/0/en/Intravacc-Announces-Review-Publication-of-OMV-based-Intranasal-Vaccines-for-Disease-Prevention.html
https://www.prnewswire.com/news-releases/intravaccs-cso-virgil-schijns-appointed-as-visiting-professor-at-the-scottish-university-of-strathclyde-in-glasgow-301754011.html